Responses
Oncolytic and local immunotherapy
Original research
Oncolytic vesicular stomatitis virus–based cellular vaccine improves triple-negative breast cancer outcome by enhancing natural killer and CD8+ T-cell functionality
Compose a Response to This Article
Other responses
No responses have been published for this article.